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ABSTRACT
Background Verbal autopsy is currently the only option
for obtaining cause of death information in most
populations with a widespread HIV/AIDS epidemic.
Methods With the use of a data-driven algorithm, a set
of criteria for classifying AIDS mortality was trained. Data
from two longitudinal community studies in Tanzania and
Zimbabwe were used, both of which have collected
information on the HIV status of the population over
a prolonged period and maintained a demographic
surveillance system that collects information on cause of
death through verbal autopsy. The algorithm was then
tested in different times (two phases of the Zimbabwe
study) and different places (Tanzania and Zimbabwe).
Results The trained algorithm, including nine signs and
symptoms, performed consistently based on sensitivity
and speciﬁcity on verbal autopsy data for deaths in
15e44-year-olds from Zimbabwe phase I (sensitivity
79%; speciﬁcity 79%), phase II (sensitivity 83%;
speciﬁcity 75%) and Tanzania (sensitivity 75%; speciﬁcity
74%) studies. The sensitivity dropped markedly for
classifying deaths in 45e59-year-olds.
Conclusions Verbal autopsy can consistently measure
AIDS mortality with a set of nine criteria. Surveillance
should focus on deaths that occur in the 15e44-year age
group for which the method performs reliably. Addition of
a handful of questions related to opportunistic infections
would enable other widely used verbal autopsy tools to
apply this validated method in areas for which HIV testing
and hospital records are unavailable or incomplete.
Verbal autopsy, in which care givers to the deceased
report information on signs, symptoms and
circumstances preceding death,
1e3 is currently the
bestoption forobtaining causeof deathinformation
in populations without comprehensive civil regis-
tration systems. WHO, through the Health Metrics
Network, is co-ordinating an effort to develop
a common tool for verbal autopsy, since there is an
urgent need to validate currently used questions for
different populations, settings and causes of
mortality.
4
There is particular need to develop methods to
measure AIDS mortality, which is the leading cause
of death among young adults in virtually all coun-
tries with generalised HIV epidemics. Improving
measurement of AIDS mortality is crucial since
the ultimate goal of interventionsdincluding the
scale up of antiretroviral treatmentdis to reduce
AIDS mortality.
5 Monitoring the success of such
programmes therefore relies on accurate measure-
ment of AIDS deaths in the community.
67Hospital
records and vital registration of deaths are especially
inadequate for estimating the level of AIDS as
a cause of mortality because of bias, underreporting
and stigma associated with the disease.
8
Two longitudinal community studies in Tanzania
and Zimbabwe provide a unique opportunity to
investigate the most sensitive and speciﬁc set of
questions to ascertain HIV/AIDS-associated
mortality. Both studies have collected information
on the HIV status of the population over
a prolonged period and maintained a demographic
surveillance system (DSS) that collects information
on cause of death through verbal autopsy. At the
time of the verbal autopsy studies, HIV prevalence
was approximately 20% in the Zimbabwe cohort
and 7% in the Tanzania cohort.
9 10 With data from
the Zimbabwe study, we developed a computer
algorithm to classify AIDS deaths from verbal
autopsy data
11 12 validated using serological data
from deaths that occurred from 1998 to 2003. Before
the algorithm can be widely used, it must be
demonstrated that it performs similarly and
predictably in different settings of high HIV-asso-
ciated mortality (validation in place) and can
perform well at different phases of the epidemic
when levels of AIDS mortality differ (validation in
time).
METHODS
All participants of both cohorts were followed as
part of demographic surveillance and were tested
for HIV at each sero-survey. If an individual died
between follow-ups, an attempt was made to
perform verbal autopsy. An individual’s HIV status
at death was assumed to be the same as at his/her
most recent test, which was a maximum of 3 years
prior.
The Manicaland Project includes a population-
based open cohort study in the rural province of
Manicaland in eastern Zimbabwe.
9 The study
population were residents in two forested small
towns, four tea and coffee estates and six rural areas
(including four subsistence farming and two road-
side trading centres). A baseline survey took place
from 1998 to 2000, with two follow-ups occurring 3
and 5 years later (the intersurvey periods are
referred to here as phase I and phase II). Of the
households, 8376 and 7102 identiﬁed in the survey
areas at phase I and phase II, respectively, were
enumerated. Male and female participation rates in
the individual cohort study survey were 78% (4320/
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Research report5561) and 80% (5134/6419) at phase I and 77% (3047/3958) and
80% (3972/4936) at phase II, respectively. Verbal autopsies were
conducted for 94% of all deaths,
9 with 53% of the verbal autopsy
reports obtained from close relatives (spouse 19%, child 7%,
parent 16% and sibling 10%). At each follow-up of the study,
testing for the presence of HIVantibody was performed.
13
The Kisesa HIV cohort is located in Magu District, Mwanza
Region, in northwestern Tanzania. The cohort was established
in 1994 (when baseline studies were conducted) and data
collection is based on a biannual DSS that had conducted 14
phases by 2002 and sero-surveys repeated approximately every
3 years, with three testing surveys completed before 2002.
10 14e17
The population in the DSS area grew from 19354 in 1994 to
24403 by 2002. Participation in the DSS is more than 98%, with
proxy reporting accepted for absent household members. The
average participation rate in sero-surveys was 72% in the ﬁrst
three surveys. Deaths identiﬁed in the DSS are followed up with
a verbal autopsy interview between 6 weeks and 6 months later,
if a reliable informant can be identiﬁed who cared for the
deceased during the ﬁnal illness. Verbal autopsy interviews were
completed for 67% (420/629) of the adult male deaths and 64%
(424/667) of the adult female deaths recorded in the DSS
between 1994 and 2002; 94% of the verbal autopsy reports were
obtained from close relatives (spouse 30%, child 28%, parent 21%
and sibling 15%).
The verbal autopsy tool
The study teams identiﬁed deaths through the use of checklists
of all individuals interviewed at the previous phase and discus-
sions with village health workers, employers and surviving
household members present at follow-up. Data were collected on
the signs, symptoms and circumstances preceding death using
a structured, closed, interviewer-led questionnaire. The verbal
autopsy questionnaire was originally developed in Kisesa and
contained speciﬁc questions related to symptoms of late-stage
HIVand opportunistic infections
14 andwas usedin thatsitefrom
1994 to 2002. A nearly identical questionnaire was adapted in
Manicaland in both phaseI and phaseII. The questionnaires were
administered in local languages (Shona, the predominant local
language in Zimbabwe, and Swahili, in Tanzania). Interviewers
were clinical ofﬁcers/certiﬁed nurses whoreceived special training
on how to administer the verbal autopsy questionnaire. Verbal
autopsy informants were parents, spouse, other relatives or
a neighbour (in rare circumstances when close relatives were not
available). The interviews were conducted after the recognised
mourning period, in a respectful and unhurried manner. In Kisesa,
the interviewer gave a small, culturally appropriate gift (a bar of
soap) to the person with whom the interview was conducted, as
a token of appreciation of the time devoted to answering the
lengthy questionnaire. Ethical approval for the DSS and all
related procedures (such as the verbal autopsy interviews) was
granted by the Tanzanian Medical Research Co-ordinating
Committee for the Kisesa study and by the Zimbabwe Medical
Research Council for the Manicaland Study.
Validation procedures
We developed a computer algorithm that creates a set of criteria
for classifying AIDS deaths based on verbal autopsy data.
12
Seventy-ﬁve per cent of deaths from Manicaland phase I were
randomly assigned to a training dataset. From this training
dataset, all signs/symptoms with a likelihood ratio >1.92 in
univariate analyses were considered as potential identiﬁers of
AIDS death (as deﬁned below). Signs/symptoms were added to
a list of criteria one at a time, based on the highest speciﬁcity.
Verbal autopsy deaths with that sign/symptom were then
removed from the dataset, and speciﬁcities of the remaining
signs/symptoms were recalculated. Sensitivity was plotted
against 1especiﬁcity in a receiver operator characteristic (ROC)
plot. (The ROC is a tool used to select an optimum cut-off for
a diagnostics test based on the trade-off of sensitivity and spec-
iﬁcity.) These steps were repeated until the (equally weighted)
sensitivity and speciﬁcity of the list of symptoms was maximised
(ie, the point closest to the top left hand corner of the ROC plot).
Deaths were classiﬁed as HIV/AIDS associated if the deceased
had one or more of the criteria on the list. The sensitivity and
speciﬁcity of the list was then tested on the Manicaland phase I
test data (the remaining 25% of deaths), all phase II and all Kisesa
data. AIDS death in the gold standard was deﬁned as an indi-
vidual who was (a) HIV positive at baseline survey based on
antibody testing; (b) was not reported to have suffered major
injury from motor vehicle accident, self-inﬂicted (suicide), or
accidentally (accident) or deliberately inﬂicted by another person
(homicide) in the 2 weeks before death; and (c) did not die from
direct obstetric causes (death during labour).
12 Preliminary
analyses highlighted that HIV prevalence among the deceased
was markedly lower among the relatively older adults, so anal-
yses were stratiﬁed at age 45 years.
RESULTS
There were a total of 376 and 219 deaths in phase I (1998e2003)
and phase II (2003e2005), respectively, of the Manicaland study
and 197 in Kisesa (1994e2002), among 19e59-year-olds for
whom there was a verbal autopsy and a conclusive HIV test done
within 3 years of death. A minority of deaths occurred in the
45e59-year age group (13%, 17% and 19%) in Manicaland phase
I, phase II and Kisesa cohorts, respectively (table 1). In Manica-
land, approximately 75% of deaths were caused by AIDS,
compared with 51% in Kisesa 15e44-year-olds and 33% among
Kisesa 45e59-year-olds. Herpes zoster, acute respiratory tract
infections, abscesses and sores, acute diarrhoea and tuberculosis
were all less commonly reported in Kisesa than in Manicaland
(table 2). For deaths under the age of 45 years, weight loss,
jaundice, tumours, respiratory tract infections and tuberculosis
were less common among HIV-positive deaths in Kisesa
compared with Manicaland.
In applying the previously developed algorithm to Kisesa data,
the sensitivity in classifying AIDS deaths was low (67%), mainly
because of poor sensitivity (46%) in the 45e59-year age group.
Table 1 Prevalence of AIDS mortality in Kisesa and Manicaland verbal autopsy subjects
Manicaland Kisesa
Phase I train Phase I test Phase I test Phase II test Phase II test Test Test
Age range (years) 15e44 15e44 45e59 15e44 45e59 15e44 45e59
Total with HIV test and VA (n) 237 88 51 181 38 158 39
AIDS deaths in gold standard (n (%)) 173 (73%) 64 (73%) 40 (78%) 137 (76%) 28 (73%) 81 (51%) 13 (33%)
VA, verbal autopsy.
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Research reportBased on this observation, the algorithm was re-trained on
Manicaland phase I data, restricted to 15e44-year-olds. This
resulted in a different ordering of symptoms compared with the
original algorithm and in the inclusion of a ninth symptom since
the addition of diarrhoea gave a slightly higher mean sensitivity
and speciﬁcity (nine symptoms: 75.1% compared with eight
symptoms: 74.7%). Using this new algorithm, a set of nine
criteria with a sensitivity of 75.0% and speciﬁcity of 75.2% was
produced (ﬁgure 1).
The newly trained algorithm performed consistently based on
sensitivity and speciﬁcity of data for 15e44-year-olds from
Manicaland phase I (sensitivity 79%; sensitivity 79%), Manicaland
phase II (sensitivity 83%; speciﬁcity 75%) and Kisesa (sensitivity
75%; speciﬁcity 74%) tests. Although a reasonable speciﬁcity was
maintained on 45e59-year-olds, the sensitivity dropped markedly
in Manicaland phase I (sensitivity 73%; speciﬁcity 73%), Manica-
land phase II (sensitivity 68%; speciﬁcity 80%) and Kisesa (sensi-
tivity 54%; speciﬁcity 62%) tests in this older age group (ﬁgure 2).
The INDEPTH network is an association of health and
DSSs in African, Asian and Oceania countries (http://www.
indepth-network.org/). The network has developed a widely
used verbal autopsy questionnaire, although the tool does not
collect information on herpes zoster, abscesses or sores, vaginal
tumours or oral candidiasis (table 3).
18 We measured the value of
using the ﬁve signs/symptoms that are available from the
INDEPTH questionnaire. In the 15e44-year-old age group, using
only these ﬁve signs/symptoms resulted in a sensitivity and
speciﬁcity of 64% and 82%, respectively (ﬁgure 2). The reduction
in sensitivity was less than expected, using the same ﬁve criteria
in phase II Manicaland data and earlier Kisesa data sensitivity
had decreased to 50% and 44% respectively.
DISCUSSION
We developed a tool that consistently measures AIDS mortality
using verbal autopsy. Through slight modiﬁcation to our previ-
ously proposed criteria, the algorithm performs similarly in
Zimbabwe and Tanzaniadsettings with different HIV preva-
lence (approximately 20% and 7%, respectively
9 10) and AIDS
mortality and different distribution of other causes of death. The
algorithm is robust in that it performs consistently when prev-
alence is above approximately 5%.
This method of measuring AIDS mortality produced reliable
estimates only in the 15e44-year age group. This is due to
increasing levels of other-cause mortality in older ages. In
Manicaland, where the proportion of deaths due to HIV in the
older age groups remained high,
11 the methods worked well. But
in Kisesa, where HIV prevalence is lower, AIDS mortality begins
to drop off after 35 years of age, especially in women.
61 41 92 0and
other causes also increase in the 45e59-year age groups. Tuber-
culosis, in particular, reduces the speciﬁcity marginally and the
sensitivity markedly
21 22 because tuberculosis symptoms
overlap substantially with HIV symptoms resulting in
misclassiﬁcation.
Given the sensitivity and speciﬁcity of the method from the
training data, we would predict that 88% and 53% of deaths of
15e44-year-olds in Manicaland and Kisesa were AIDS deaths,
respectively. (The formulae for this calculation are described by
Lopman et al.
12) This compares with directly measured values of
76% and 51%. The overestimate in Manicaland is a result the
algorithm actually performing better in phase II (higher speci-
ﬁcity) than it did on the training dataset. To calculate the prev-
alence of AIDS death, the level of misclassiﬁcation is corrected;
however, the level of misclassiﬁcation was actually smaller than
calculated on the training data. This approach to estimation of
AIDS deaths can be applied to other verbal autopsy data for
which a gold standard is not available; however, the accuracy of
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Figure 1 Receiver operator characteristic (ROC) curve of algorithm on
deaths of 15e44-year-olds from Manicaland phase I.
Table 2 Sensitivity and speciﬁcity of individual signs and symptoms for AIDS deaths in Manicaland and Kisesa cohorts, stratiﬁed at age 45 years
Symptom
Train Test
Manicaland
phase I
Manicaland
phase II Manicaland phase II Kisesa
15e44 years
(n[237)
15e59 years
(n[102)
15e44 years
(n[180)
45e59 years
(n[38)
15e44 years
(n[158)
45e59 years
(n[39)
Se Sp Se Sp Se Sp Se Sp Se Sp Se Sp
Weight loss 9 100 10 99 12 98 0 91 10 96 23 84
Herpes zoster 12 93 18 95 24 98 19 100 14 97 8 100
Jaundice 19 93 4 97 4 100 0 100 5 99 8 96
Vaginal tumours 6 94 6 94 3 100 0 100 0 100 0 96
Wasting 19 93 19 95 15 95 13 100 16 95 8 100
ARTI 11 95 10 95 8 95 13 100 5 96 0 88
Abscesses or sores 24 90 24 92 29 98 32 100 19 96 8 100
Oral candidiasis 38 86 37 89 45 86 26 91 40 92 15 100
Diarrhoea 17 95 17 92 29 93 23 100 10 92 8 88
Recent TB* 27 86 28 88 47 82 32 100 5 99 8 96
ARTI, acute respiratory tract infections; Se, sensitivity; Sp, speciﬁcity; TB, tuberculosis.
*Recent tuberculosis is shown for information but was not included in the ﬁnal algorithm due poor speciﬁcity.
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Research reportTable 3 Signs and symptoms for surveillance of AIDS mortality, and the availability in INDEPTHdanother widely used verbal autopsy questionnaire
Sign/symptom Deﬁnition based on verbal autopsy question Equivalent in INDEPTH VA questionnaire
Weight loss Moderate or severe weight loss with no other symptoms of
malnutrition
Yes
Herpes zoster Ever suffered from zoster Not speciﬁcally mentioned (shingles, zoster, herpes) but questions
on rash, including where the rash is located (not if it is one-sided)
and if the rash has blisters. No mention of pain during or after rash
Jaundice Acute jaundice (yellowing of the whites of the eyes during the
disease that lead to death) with fever and/or itching but without
history of alcohol abuse
Yes
Vaginal tumours Vaginal tumour for at least 1 month with or without bleeding No
Wasting Moderate or severe weight loss with at least four of the following
symptoms: paleness, changing hair colour, oedema of legs, burning
sensations of the feet, dry scaly skin
Two out of the ﬁve symptoms (but different phrasing): paleness
oedema of ankles. No mention of changing hair colour, burning feet
dry scaly skin (might be identiﬁed as rash)
Acute respiratory tract illness Trouble breathing, cough lasting 3e27 days with fever but not
recent TB, weight loss or wasting, as above
Partial cough, with duration fever shortness of breathing noisy
breathing. TBddoes not specify when
Abscesses or sores Had abscesses or sores No sores not mentioned, “other swellings or ulcers”
Oral candidiasis Had two or three of the following: ulcers in the mouth, difﬁculty
swallowing, white patches inside the mouth and tongue
No difﬁculty swallowing
Diarrhoeal disease Loose stools lasting 3e99 days, with or without dehydration Yes
TB, tuberculosis; VA, verbal autopsy.
Figure 2 Sensitivity and speciﬁcity of the trained
algorithm. The dashed line represents the performance of
the algorithm on the training dataset. Panels A to D use
the full set of nine signs and symptoms. Panels E and F
use a smaller set of ﬁve signs/symptoms available from
the current INDEPTH tool.
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Research reportthe prediction will not be known. Therefore, further validation of
the algorithm is recommended.
The INDEPTH verbal autopsy is a widely used tool that used
a shorter symptom list than ours and does not collect infor-
mation to identify herpes zoster, oral candidiasis, abscesses/sores
or vaginal tumours.
21 These symptoms were commonly reported
in our studies and (excluding vaginal tumours) were prevalent in
AIDS deaths with a sensitivity of approximately 20% for zoster
and abscesses/sores and 40% for oral candidiasis. We found that
the INDEPTH shortlist would perform less well and have higher
levels of misclassiﬁcation of AIDS deaths.
23 The newly released
WHO instrument includes signs and symptoms associated with
herpes zoster, abscesses/sores and oral candidiasis.
4 In general,
verbal autopsy have only proved accurate enough to assign cause
of death in very broad categories in adults. However, statistical or
algorithmic approaches, such as the method used here, have been
shown to perform adequately for determining prevalence of
a speciﬁc cause, such as HIV. Unfortunately, causes of death other
than HIV could not be validated, as neither physician assessment
nor diagnostics data were routinely available.
Our analyses show that in areas of generalised epidemics,
verbal autopsy can consistently measure AIDS mortality. Both
studies had HIV prevalence levels exceeding 5%, which is
commonly found in eastern and southern Africa. In settings
where prevalence is less than 5%, getting AIDS mortality from
verbal autopsy may be difﬁcult and will require further valida-
tion studies. Even in higher prevalence settings, analyses should
be restricted to age groups in which competing causes of
mortality, especially other infectious causes, are relatively low.
Especially for the Tanzanian population, the verbal autopsy
method was much less accurate for deaths over the age of
45 years. Based on our analyses, we recommend surveillance of
deaths in populations with severe HIVepidemics be undertaken
in the 15e44-year age group. Addition of a handful of questions
related to opportunistic infections would enable other widely
used verbal autopsy tools (WHO and INDEPTH) to apply this
validated method in areas where HIV testing and hospital records
are unavailable or incomplete.
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What is already known on this topic
Verbal autopsy is currently the best option for obtaining cause of
death information in populations without comprehensive civil
registration systems. Verbal autopsy is generally used to assign
deaths to broad categories and estimate cause-speciﬁc
mortality.
What this study adds
We demonstrate that verbal autopsy can consistently measure
AIDS mortality with a simple set of nine criteria. Surveillance
should focus on deaths that occur in the 15e44-year age group
for which the method performs reliably. Adding just a handful of
questions related to opportunistic infections would enable other
widely used verbal autopsy tools to apply this validated method
to asses AIDS mortality in areas where HIV testing and hospital
records are unavailable or incomplete.
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